MalarVx, Inc. — Form D/A
MalarVx, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2015-01-30. The offering totals $900K, of which $110K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-01-30
- Form: D/A
- Accession: 0001559688-15-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $900K
- Amount sold: $110K
- Remaining: $790K
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2015-01-02
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-232492
Issuer
- Name: MalarVx, Inc.
- CIK: 0001559688
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2012
- Address: 307 WESTLAKE AVENUE NORTH, SEATTLE, WA, 98109
- Phone: 206-200-8541
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| James Wayne Davie | Director | Seattle, WA |
| James Wayne Davie | Executive Officer | Seattle, WA |
Other filings by this issuer (4)
More